Aripiprazole
Tractiva contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat adults and adolescents aged 15 years and older who suffer from a disease characterized by symptoms such as: hearing, seeing or feeling things that are not real, suspiciousness, beliefs that are not based on reality, chaotic speech and behavior, and emotional numbness. Patients with these symptoms may also experience depression, guilt, anxiety, or tension. Tractiva is used to treat adults and adolescents aged 13 years and older whose disease is characterized by symptoms such as: severe excitement, excessive energy, reduced need for sleep, very rapid speech, racing thoughts, and sometimes extreme irritability. In adults, this medicine also prevents the recurrence of these symptoms in patients who have responded to treatment with Tractiva.
Before starting treatment with Tractiva, you should discuss it with your doctor. During treatment with aripiprazole, thoughts and behaviors of suicide have been reported. You should immediately inform your doctor if you experience thoughts or feelings related to self-harm. Before starting treatment with Tractiva, you should tell your doctor if you have:
If you notice an increase in weight, appearance of unusual movements, drowsiness that interferes with daily activities, any difficulty swallowing, or symptoms of an allergy, you should tell your doctor. If an elderly patient has dementia, they or their caregiver or relative should inform the doctor if the patient has ever had a stroke or "mini" stroke. You should immediately inform your doctor if you experience thoughts or feelings related to self-harm. During treatment with aripiprazole, thoughts and behaviors of suicide have been reported. You should immediately inform your doctor if you experience stiffness of the muscles or stiffness with high fever, sweating, disturbances of consciousness, or very rapid or irregular heartbeat. If you or your family or caregiver notice that you start to feel the urge or desire to behave in an unusual way, and that you cannot resist the impulse, drive, or temptation to engage in activities that may harm you or others, you should tell your doctor. These phenomena are called impulse control disorders and may manifest as behaviors such as compulsive gambling, overeating, or excessive spending, excessive sexual drive, or increased frequency and intensity of thoughts or feelings about sexual topics. Your doctor may consider changing the dose or discontinuing the medicine. Aripiprazole may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in the ability to move and maintain balance, which can lead to falls. You should be careful, especially in elderly or weakened patients.
This medicine should not be used in children and adolescents under 13 years of age. It is not known if the use of this medicine is safe and effective in these patients.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take, including those available without a prescription. Blood pressure-lowering medicines: Tractiva may enhance the effects of blood pressure-lowering medicines. If you are taking blood pressure-lowering medicines, you should tell your doctor. The use of Tractiva with other medicines may require a change in the dose of Tractiva or other medicines you are taking. It is especially important to inform your doctor about the use of:
Taking these medicines may increase the risk of side effects or decrease the effect of Tractiva; if you experience any unusual symptoms while taking these medicines together with Tractiva, you should tell your doctor. Medicines that increase serotonin levels are usually used in diseases including depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social anxiety disorder, as well as migraine and pain:
These medicines may increase the risk of side effects; if you experience any unusual symptoms while taking these medicines together with Tractiva, you should tell your doctor.
This medicine can be taken with or without food. You should avoid drinking alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should ask your doctor for advice before taking this medicine. In newborns whose mothers took Tractiva during the last trimester (last 3 months of pregnancy), the following symptoms may occur: trembling, stiffness, and/or muscle weakness, drowsiness, agitation, breathing difficulties, and feeding difficulties. If you notice any of these symptoms in your baby, you should contact your doctor. If you are taking Tractiva, your doctor will discuss with you whether you should breastfeed, considering the benefits of treatment and the benefits of breastfeeding. You should not take this medicine and breastfeed at the same time. You should talk to your doctor about the best way to feed your baby if you are taking this medicine.
During treatment with this medicine, dizziness and vision disturbances may occur (see section 4). You should take this into account when performing tasks that require full attention, such as driving or operating machinery.
If you have been told that you have an intolerance to some sugars, you should contact your doctor before taking this medicine.
This medicine should always be taken exactly as your doctor or pharmacist has told you. If you are not sure, you should ask your doctor or pharmacist. The recommended dose of Tractiva for adults is 15 mg once a day.However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg a day.
Aripiprazole treatment may be started at a low dose in the form of an oral solution (liquid). The dose may be gradually increased to the recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg a day. If you feel that the effect of Tractiva is too strong or too weak, you should talk to your doctor or pharmacist. Tractiva tablets should be taken once a day at the same time every day.It does not matter whether you take the tablet with or without food. The tablet should be swallowed whole and washed down with water. Even if you feel better, you should not change the dose or stop taking Tractiva without first talking to your doctor.
If you have taken more Tractiva than your doctor recommended (or if someone else has taken some of your Tractiva), you should contact your doctor immediately. If you have trouble contacting your doctor, you should go to the nearest hospital, taking the packaging of the medicine with you. In patients who have taken too much aripiprazole, the following symptoms have occurred:
Other symptoms may include:
If you experience any of these symptoms, you should contact your doctor or hospital immediately.
If you miss a dose, you should take the missed dose as soon as you remember, but you should not take two doses in one day.
You should not stop treatment, even if you feel better. It is very important to take Tractiva as your doctor has told you and for as long as your doctor has told you. If you have any further questions about the use of this medicine, you should ask your doctor or pharmacist.
Like all medicines, Tractiva can cause side effects, although not everybody gets them. Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
The following side effects have been reported after the marketing of aripiprazole in oral form, but the frequency of their occurrence is unknown:
In elderly patients with dementia taking aripiprazole, more cases of death have been reported. Additionally, cases of stroke or "mini" stroke have been noted.
In adolescents aged 13 years and older, side effects occurred with a similar frequency and type as in adults, except for drowsiness, uncontrolled trembling, or sudden movements, restlessness, and fatigue, which occurred very frequently (may occur in more than 1 in 10 patients), and abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle tremors, uncontrolled movements of the limbs, and dizziness, especially when standing up from a lying or sitting position, which occurred frequently (may occur in more than 1 in 100 patients).
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49 21 301, fax: 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of the sight and reach of children. Do not use this medicine after the expiry date stated on the blister and carton after "EXP". The expiry date refers to the last day of the month. There are no special precautions for storage. Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Tractiva 5 mg, tablets: Round, flat tablet, pink. Tractiva 10 mg, tablets: Round, biconvex tablet, pink. Tractiva 15 mg, tablets: Round, biconvex tablet, pink with a score line on one side. The score line is not intended for breaking the tablet. Tractiva 20 mg, tablets: Round, flat tablet, pink with "20" engraved on one side and a score line on the other side. The score line is not intended for breaking the tablet. Tractiva 30 mg, tablets: Round, biconvex tablet, pink. The medicine is available in aluminum/aluminum blisters, packaged in cardboard boxes containing 14 or 28 tablets. Not all pack sizes may be marketed.
Exeltis Poland Sp. z o.o. ul. Szamocka 8 01-748 Warsaw e-mail: biuro@exeltis.com
Laboratorios Liconsa, S.A. Avda. Miralcampo, Nº 7, Polígono Industrial Miralcampo 19200 Azuqueca de Henares Guadalajara Spain
Belgium Tractiva 5 mg, 10 mg, 15 mg, 20 mg, 30 mg tablets / tablets / tablets Czech Republic Tractiva Spain Aripiprazol Laboratorios Liconsa 5 mg EFG; Aripiprazol Laboratorios Liconsa 10 mg EFG; Aripiprazol Laboratorios Liconsa 15 mg EFG; Aripiprazol Laboratorios Liconsa 20 mg; Aripiprazol Laboratorios Liconsa 30 mg EFG Iceland Tractiva Luxembourg Tractiva 5 mg, 10 mg, 15 mg, 20 mg, 30 mg tablets Germany Aripiprazol AAA-Pharma 5 mg, 10 mg, 15 mg, 20 mg, 30 mg tablets Poland Tractiva Italy Tractiva Date of last revision of the leaflet:11.07.2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.